Barclays PLC Increases Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

Barclays PLC grew its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 375.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,101 shares of the company's stock after acquiring an additional 38,763 shares during the quarter. Barclays PLC owned about 0.14% of The Pennant Group worth $1,753,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. FMR LLC lifted its holdings in The Pennant Group by 51.3% in the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company's stock valued at $90,268,000 after purchasing an additional 856,838 shares in the last quarter. Crewe Advisors LLC raised its position in shares of The Pennant Group by 1.6% in the third quarter. Crewe Advisors LLC now owns 742,958 shares of the company's stock valued at $26,524,000 after buying an additional 11,927 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of The Pennant Group by 0.4% during the third quarter. Geode Capital Management LLC now owns 682,132 shares of the company's stock valued at $24,357,000 after buying an additional 2,963 shares during the period. First Eagle Investment Management LLC boosted its position in The Pennant Group by 2.1% during the second quarter. First Eagle Investment Management LLC now owns 391,748 shares of the company's stock worth $9,085,000 after acquiring an additional 8,000 shares during the last quarter. Finally, De Lisle Partners LLP grew its stake in The Pennant Group by 7.6% in the 3rd quarter. De Lisle Partners LLP now owns 343,340 shares of the company's stock worth $12,254,000 after acquiring an additional 24,321 shares during the period. Institutional investors and hedge funds own 85.88% of the company's stock.

The Pennant Group Trading Down 2.8 %

NASDAQ:PNTG traded down $0.75 on Friday, hitting $25.82. 201,836 shares of the stock were exchanged, compared to its average volume of 241,206. The stock has a market cap of $886.87 million, a PE ratio of 37.97, a PEG ratio of 2.99 and a beta of 1.93. The Pennant Group, Inc. has a fifty-two week low of $14.84 and a fifty-two week high of $37.13. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58. The stock has a fifty day moving average of $29.59 and a 200-day moving average of $30.69.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Wells Fargo & Company started coverage on The Pennant Group in a research note on Thursday, December 19th. They set an "equal weight" rating and a $33.00 price target on the stock. Truist Financial reduced their target price on The Pennant Group from $38.00 to $32.00 and set a "hold" rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada lifted their price target on The Pennant Group from $26.00 to $38.00 and gave the company an "outperform" rating in a report on Wednesday, October 23rd. Stephens reiterated an "overweight" rating and set a $40.00 price objective on shares of The Pennant Group in a report on Wednesday, October 9th. Finally, Oppenheimer raised their target price on shares of The Pennant Group from $34.00 to $37.00 and gave the stock an "outperform" rating in a research report on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, The Pennant Group has an average rating of "Moderate Buy" and an average price target of $36.00.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.